Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Theophylline by Cyrano Therapeutics for Hyposmia: Likelihood of Approval
Theophylline is under clinical development by Cyrano Therapeutics and currently in Phase II for Hyposmia. According to GlobalData, Phase II...